Results 311 to 320 of about 118,639 (364)
Some of the next articles are maybe not open access.
Design and development of polysaccharide hemostatic materials and their hemostatic mechanism
Biomaterials Science, 2017The formation of stable blood clots or hemostasis is essential to prevent major blood loss and death from excessive bleeding.
Xiao Yang +9 more
openaire +2 more sources
Hemostatic Resuscitation in Children
Transfusion Medicine Reviews, 2021Trauma is a major source of morbidity and mortality for children worldwide; life-threatening hemorrhage is a primary cause of preventable death. Essential interventions in children with life-threatening hemorrhage include hemostatic resuscitation and mechanical control of bleeding.
Rafael G. Ramos-Jimenez +1 more
openaire +2 more sources
Epistaxis and Hemostatic Devices
Oral and Maxillofacial Surgery Clinics of North America, 2012Epistaxis is a common medical problem that rarely requires surgical intervention. However, when medical or surgical intervention is required, epistaxis can sometimes be difficult to control. Knowledge of nasopharyngeal anatomy is absolutely essential to the proper management of epistaxis.
Levon, Nikoyan, Stanley, Matthews
openaire +2 more sources
Hemostatic Strategies in Trauma
AACN Advanced Critical Care, 2021Bleeding is a leading cause of early death from trauma. Consequently, effective hemostasis can improve the odds of survival after severe traumatic injury. Understanding the pathophysiology of trauma-induced coagulopathy can provide insights into effective strategies to assess and halt hemorrhage.
openaire +2 more sources
Hemostatic Multilayer Coatings
Advanced Materials, 2011Spray layer-by-layer assembly is used to create hemostatic films containing thrombin and tannic acid. The spray assembly technique enables coating of porous and absorbent commercial gelatin sponges with these films. Coated sponges are able to promote instantaneous hemostasis in a porcine spleen bleeding model.
Anita, Shukla +4 more
openaire +2 more sources
Local hemostatic agent - fluid active hemostatic matrix
Khirurgiya. Zhurnal im. N.I. Pirogova, 2019Uncontrolled surgical bleeding can have significant clinical and economic consequences including advanced medical expenses and impairment of the outcomes. Effective and safe local hemostatic agents based on a fluid active hemostatic matrix are reviewed in the article.
openaire +2 more sources
Hemostatic changes in vasculitides
Thrombosis Research, 2009The systemic vasculitides are an heterogeneous group of rare diseases characterized by inflammation and fibrinoid necrosis of blood vessel walls. Today it is well known that the inflammatory process characterizing vasculitides activates coagulation factors, inhibits anticoagulant factors, inhibits fibrinolytic processes, increases platelet activity and
TRIFILETTI A +3 more
openaire +2 more sources
Seminars in Thrombosis and Hemostasis, 2015
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +3 more sources
The mainstay of treatment of inherited coagulation disorders is based on the infusion of the deficient clotting factor, when available. Significant advances have been made over the past two decades in the production and availability of factor replacement products.
Franchini, Massimo +2 more
openaire +3 more sources
Hemostatic Suture of the Liver
Archives of Surgery, 1976• A technique for rapid placement of hemostatic sutures in the liver has been used without complications in 12 patients. Using a long, thin needle, a double row of interlocking sutures can be placed quickly and accurately. The technique is simple, requires no special training or complicated instrumentation, and provides effective hemostasia.
A, Arango, L, Lester
openaire +2 more sources
Hemostatic Agents and Their Safety
Journal of Cardiothoracic and Vascular Anesthesia, 1999The pharmacologic management of hemostasis in patients undergoing cardiopulmonary bypass may be accompanied by adverse responses. Evaluating the safety profile of hemostatic agents (eg, lysine analogs, aprotinin, protamine, or even donor blood) should be done objectively.
openaire +2 more sources